Clinical Trials Directory

Trials / Terminated

TerminatedNCT01131572

N-acetylcysteine in Bulimia Nervosa

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Lindner Center of HOPE · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study tests NAC in the treatment of Bulimia Nervosa.

Conditions

Interventions

TypeNameDescription
DRUGN-acetylcysteine NACN-acetylcysteine in the treatment of Bulimia Nervosa

Timeline

Start date
2010-02-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2010-05-27
Last updated
2013-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01131572. Inclusion in this directory is not an endorsement.